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INTRODUCTION 
Urolithiasis is the process of formation of stones in 
kidney, urethra or bladder. It is associated with pain in 
abdomen, flank or groin. The stones are formed due to 
decreased urine output or increased excretion of 
constituents like calcium, oxalate, urate and phosphate 
which are responsible for the formation of stone. It 
occurs in people with frequent urinary tract infections 
or using antacid in excessive amount, has 
hypophosphatemia and hypercalciuria
1
. Herbs have 
been used traditionally for the treatment of urolithiasis
2
 
and pain
3
.  Many experimental studies have been done 
on combination of herbs
4,5
. Therefore an oral 
suspension containing three medicinal herbs was 
prepared for the study of antiurolithiatic activity. These 
drugs were Cyperus rotundus L. (Cyperaceae), 
Azadirachta indica A. Juss (Meliaceae) and  
Bryophyllum pinnatum Lam., (Crassulaceae). 
Cyperus rotundus has antidiarrhoeal
6,7
,  analgesic, 
antipyretic and anti-inflammatory
8,9 
 diuretic, 
antispasmodic and litholytic
10,11 
activity. It is used in 
stomach pain
12
.  Azadirachta indica is reported to have 
hepatoprotective
13
, antioxidant
14
, anti-inflammatory
15
, 
immunomodulatory
16 
and antiurolithiatic activity
17
.  
Studies show that Bryophyllum pinnatum have good 
antiurolithiatic
18-21
, antimicrobial
22,23 
 and 
nephroprotective
24
 activity. Considering the presence of 
antiurolithiatic activity, antimicrobial, analgesic and 
anti-inflammatory activities in these drugs a polyherbal 
formulation was prepared and evaluated for 
antiurolithiatic activity. 
MATERIALS AND METHOD 
Plant material 
Collection of the roots of Cyperus rotundus (CR), 
leaves of Azadirachta indica (AI) and Bryophyllum 
pinnatum (BP) was done locally and authenticated from 
the Department of Botany, Janata PG College, A.P.S. 
University, Rewa (M.P.). The voucher specimen 
number is JC/B/PAN/054a-c. They were shade dried, 
grinded to get their coarse powders and stored in well 
closed containers.  
Preparation of polyherbal suspension (PHS) 
The coarsely powdered plant material was macerated 
separately with alcohol for 7 days, filtered and 
concentrated to get the extracts of CR, BP and AI. Each 
extract was weighed individually and mixed in a ratio of 
2:1:1. It was well triturated with Tween 80. Gradually 
distilled water was added to get a well dispersed 
suspension. 
Animals 
Male wistar albino rats weighing between 140 to 180 
gm were kept under standard laboratory conditions with 
12 hrs. light and dark cycle, temperature 25±2°C, 
relative humidity 60±5% standard pellet diet and water 
ad libitum. The experiment was approved (approval no. 
1413/PO/a/11/CPCSEA) by the Institutional Animal 
Ethics Committee as per CPCSEA guidelines (protocol 
approval no. SBRL/IAEC/2013/03). 
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ABSTRACT 
A polyherbal suspension was prepared for use in urolithiasis. Three drugs namely Cyperus rotundus roots, Azadirachta indica 
leaves and Bryophyllum pinnatum leaves were used in the formulation. Antiurolithiatic activity was studied in the ethylene 
glycol induced urolithiasis model at a dose of 100, 200 and 300mg/kg polyherbal suspension in wistar rats. Cystone was used 
as the standard drug. All the doses were found to be effective in a dose related manner. There was an increase in the urinary 
excretion of calcium, oxalate, phosphate, urea, uric acid and creatinine significantly in the suspension treated group. 
P<0.001was obtained when compared to control. The results show that the polyherbal suspension has prevented or decreased 
the supersaturation of urine leading to prevention of stone formation and agglomeration. The excretion of these ions was much 
lesser when compared to the negative control group. The dose of 300mg/kg of polyherbal suspension had activity quite similar 
to that of the standard drug cystone. Thus we conclude that the formulated polyherbal suspension has potential antiurolithiatic 
activity. 
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Acute toxicity 
Acute toxicity studies were done as per OECD 
guidelines. A dose of 250, 500, 750, 1000, 1500 and 
2000mg/kg was given to the rats. They were observed 
for any physiological or behavioural changes. 
Antiurolithiatic activity 
Ethylene Glycol induced urolithiasis
25-27     
  
The activity was studied in Ethylene glycol induced 
hyperoxaluria model. Six group were prepared having 
six rats in each group. They were given their doses 
orally. Group I- Served as normal control. GroupII- was 
treated as negative control and was given ethylene glycol 
(0.75%) in drinking water for 28 days, to induce renal 
calculi. Group III to VI were administered ethylene 
glycol (0.75%) in drinking water for 28 days. In addition 
they were given their respective doses orally from 15
th
 to 
28
th
 day. Group III was given Standard Cystone 
500mg/kg, Group IV - PHS 100mg/kg, Group V - PHS 
200mg/kg and Group VI - PHS 300mg/kg. 
Collection and analysis of urine
28-30
  
After completion of dosing the animals were transferred 
to metabolic cages for collection of urine samples which 
were estimated for calcium, oxalate and phosphate. Table 
1, Fig. 1  
Collection of blood and serum analysis
31 
Retro-orbital puncture was done to collect the blood 
samples from rats. The blood sample was kept aside for 
30 minutes at room temperature. It was than centrifuged 
at 3000 rpm, 20°C for 15 minutes and analyzed for urea, 
uric acid and creatinine. Table 2, Fig 2.  The rats were 
sacrificed, kidney was removed and used for 
histopathological examination. Fig 3. 
 
Table 1: Effect of polyherbal suspension on urinary parameters 
S. 
no. Group Treatment 
Urinary Parameters (mg/dl) 
Calcium Oxalate Phosphate 
1 I Normal control 2.52±0.18 0.87±0.02 3.42±0.11 
2 II Negative control 4.48±0.1a*** 2.72±0.15a*** 7.37±0.16a*** 
3 III Cystone 500mg/kg 2.91±0.08 b*** 1.69±0.04a***, b*** 4.19±0.24a*, b*** 
4 IV PHS 100mg/kg 3.45±0.03 a***,b*** 1.94±0.06 a***, b*** 5.95±0.19 a***, b*** 
5 V PHS 200mg/kg 3.52±0.13 a***,b*** 1.9±0.16 a***, b*** 5.46±0.13 a***, b*** 
6 VI PHS 300mg/kg 3.04±0.12 b*** 1.75±0.05a***, b*** 5.26±0.04 a***,b*** 
 All values are mean ± SEM, n = 6,   *p<0.05, **p<0.01, ***p<0.001  
a- significant difference as compared to Normal control (Group-I) 
b- Significant difference as compared to Negative control (Group-II)   
 
Figure 1: Effect of Polyherbal suspension on urinary parameters 
Table 2: Effect of  polyherbal suspension on serum parameters. 
 
 All values are mean ± SEM, n = 6,   *p<0.05, **p<0.01, ***p<0.001  
a- significant difference as compared to Normal control (Group-I) 
b- Significant difference as compared to Negative control (Group-II)   
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S. 
no. 
Group Treatment 
Serum Parameter (mg/dl) 
Creatinine Uric acid Urea 
1 I Normal control 0.65±0.06 1.29±0.09 36.91±0.19 
2 II Negative control 1.57±0.07 a*** 3.42±0.11 a*** 71.79±1.95 a*** 
3 III Cystone 500mg/kg 1.16±0.04 a***,b*** 1.85±0.12 b*** 54.16±1.55 a***,b*** 
4 IV PHS 100mg/kg 1.45±0.03a*** 2.61±0.17 a***,b*** 61.47±2.06 a***,b*** 
5 V PHS 200mg/kg 1.35±0.04a***, b* 2.51±0.2 a***,b*** 58.74±0.17 a***,b*** 
6 VI PHS 300mg/kg 1.37±0.02a*** 2.23±0.05 a***,b*** 53.98±0.13 a***,b*** 
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Figure 2: Effect of Polyherbal suspension on serum parameters 
Histopathology 
                    
(a) Normal Control                                      (b)    STZ Negative control 
                    
( c) Standard – Cystone   (d)  PHS (100 mg/kg) 
             
(e) PHS (200 mg/kg)                                       (f)  PHS (300 mg/kg) 
Figure 3: Histology of sections of kidney for antiurolithatic activity of PHS. 
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Statistical analysis 
The data was analysed by ANOVA and posthoc Tukey-
Kramer Multiple Comparisons Test by employing 
statistical software, GraphPad InStat 3. Differences 
between groups were considered significant at P < 0.05. 
All the values are expressed as mean±standard error of 
mean (S.E.M.). 
Results 
The formulation did not produce any abnormal 
behavioural changes or toxicity till the dose of 
2000mg/kg. The data in Table 1 reveals an increase in 
the excretion of calcium, oxalate and phosphate in the 
ethylene glycol treated groups especially in negative 
control group. The polyherbal suspension significantly 
(P<0.001) enhanced the excretion of these ions at all 
dose levels thereby reducing the formation of stone. A 
dose of PHS 300mg/kg and cystone were able to bring 
the level of calcium to almost normal.  All the doses of 
PHS were able to lower creatine, uric acid and urea 
significantly (P<0.001). Histology of kidney shows that 
in all the ethylene glycol treated animals the tissues are 
degenerated having vacuoles and obstructions when 
compared to the normal group but cystone and PHS have 
protected and/or regenerated the tissues. 
DISCUSSION AND CONCLUSION 
The polyherbal formulation is found to be safe till a dose 
of 2000mg/kg. Excess calcium, oxalate and phosphate 
lead to supersaturation of urine and formation of stones. 
Lithiasis occurs because of the supersaturation of urine 
due to hyperoxaluria and hypercalciuria
32
. Oxalates play 
an important role in stone formation and have about 15-
fold greater effect than urinary calcium
33
. Hyperoxaluria 
can lead to formation of calcium oxalate
34
 and increase 
in urinary phosphorus cause calcium phosphate 
crystals
35
. 
As urolithiasis is associated with pain and inflammation, 
the polyherbal formulation was prepared with herbs 
having diuretic, antimicrobial, analgesic, anti-
inflammatory and antiurolithiatic activity. The 
polyherbal suspension was found to be safe and effective 
in expelling excess urinary calcium, oxalate, phosphate, 
creatine, uric acid and urea resulting in antiurolithiatic 
effect. It is preventing and/or dissolving the formed 
stones which can be seen from the data when compared 
to the negative control group. 
Thus it can be concluded that the prepared polyherbal 
suspension can be used as a safe and effective 
antiurolithiatic formulation. It can be a boon to people 
suffering from lithiasis who have to undergo lithotripsy 
or surgery. 
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